Mr. George Wentworth reports

DELPHX ANNOUNCES CONVERTIBLE DEBENTURE PRIVATE PLACEMENT

Delphx Capital Markets Inc. has initiated a non-brokered convertible debenture private placement financing consisting of a $125,000 principal amount convertible debenture. The debenture will bear interest at a rate of 8 per cent per annum, mature one year from the date of issuance and be convertible into up to 2.5 million common shares of Delphx at a conversion price of five cents per share.

Completion of the offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the offering will be subject to a hold period of four months plus one day from the date of issuance.

Delphx intends to use the net proceeds from the offering in connection with working capital/corporate overhead.

Delphx is also providing clarification in relation to its previous private placement closing announced on April 29, 2026, that the company paid finders' fees of $3,500 and issued 87,500 finders' warrants. Each finder's warrant entitles the holder thereof to purchase one common share at an exercise price of eight cents per common share until 5 p.m. Toronto time on April 22, 2028.

About Delphx Capital Markets Inc.

Delphx is a technology and financial service company focused on developing and distributing the next generation of structured products. Through its special-purpose vehicle Quantem LLC, the company enables broker dealers to offer new private placement securities that provide for both fixed-income and cryptocurrency solutions. The new Delphx securities will enable dealers and their qualified institutional investors accounts to competitively structure, sell and make markets in:

• Collateralized put options that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
• Collateralized reference notes that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by U.S. Bank. CPOs and CRNs are proprietary products created and owned by Delphx Capital Markets.